Role of systemic and mucosal immune responses in reciprocal protection against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection

Infection and Immunity

Volumn 71, Issue 2, 2003, Pages 733-738

  Watanabe, Mineo ^a   Nagai, Masaaki ^b  

^a DAIICHI UNIVERSITY OF PHARMACY   (Japan)

^b KITASATO INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

SECRETORY IMMUNOGLOBULIN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL IMMUNITY; BACTERIAL STRAIN; BORDETELLA PARAPERTUSSIS; BORDETELLA PERTUSSIS; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; LUNG LAVAGE; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SPLEEN CELL;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES, BACTERIAL; BORDETELLA; BORDETELLA INFECTIONS; BORDETELLA PERTUSSIS; BRONCHOALVEOLAR LAVAGE FLUID; DISEASE MODELS, ANIMAL; FEMALE; IMMUNE SERA; IMMUNITY, MUCOSAL; IMMUNIZATION, PASSIVE; MICE; MICE, INBRED BALB C; RESPIRATORY TRACT INFECTIONS; SPLEEN; WHOOPING COUGH;

EID: 0037306673     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.2.733-738.2003     Document Type: Article

References (22)

1. Asahi, Y., T. Yoshikawa, I. Watanabe, T. Iwasaki, H. Hasegawa, Y. Sato, S. Shimada, M. Nanno, Y. Matsuoka, M. Ohwaki, Y. Iwakura, Y. Suzuki, C. Aizawa, T. Sata, T. Kurata, and S. Tamura. 2002. Protection against influenza virus infection in polymeric Ig receptor knockout mice immunized intranasally with adjuvant-combined vaccines. J. Immunol. 168:2930-2938.
2. Edward, K. M., M. D. Decker, and E. A. Mortimer, Jr. 1999. Pertussis vaccine, p. 293-344. In S. A. Plotkin and W. A. Orenstein (ed.), Vaccines, 3rd ed. W. B. Saunders, Philadelphia, Pa.
3. Ghendon, Y. 1989. The immune response of humans to live and inactivated influenza vaccines. Adv. Exp. Med. Biol. 257:37-45.
4. Gregorius, K., S. Mouritsen, and H. I. Eisner. 1995. Hydrocoating: a new method for coupling biomolecules to solid phases. J. Immunol. Methods 181:65-73.
5. Griffiths, E. 1988. Efficacy of whole-cell pertussis vaccine, p. 353-374. In A. C. Wardlaw and R. Parton (ed.), Pathogenesis and immunity in pertussis. John Wiley & Sons Ltd., Chichester, United Kingdom.
6. Heininger, U., K. Stehr, P. Christenson, and J. D. Cherry. 1999. Evidence of efficacy of the Lederle/Takeda acellular pertussis component diphtheria and tetanus toxoids and pertussis vaccine but not the Lederle whole-cell component diphtheria and tetanus toxoids and pertussis vaccine against Bordetella parapertussis infection. Clin. Infect. Dis. 28:602-604.
7. Heininger, U., K. Stehr, S. Schmitt-Grohe, C. Lorenz, R. Rost, P. D. Christenson, M. Uberall, and J. D. Cherry. 1994. Clinical characteristics of illness caused by Bordetella parapertussis compared with illness caused by Bordetella pertussis. Pediatr. Infect. Dis. J. 13:306-309.
8. Jabbal-Gill, I., A. N. Fisher, R. Rappuoli, S. S. Davis, and L. Illum. 1998. Stimulation of mucosal and systemic antibody responses against Bordetella pertussis filamentous haemagglutinin and recombinant pertussis toxin after nasal administration with chitosan in mice. Vaccine 16:2039-2046.
9. Khelef, N., B. Danve, M. J. Quentin-Millet, and N. Guiso. 1993. Bordetella pertussis and Bordetella parapertussis: two immunologically distinct species. Infect. Immun. 61:486-490.
10. Lautrop, H. 1971. Epidemics of parapertussis. 20 Years' observations in Denmark. Lancet i:1195-1198.
11. Liew, F. Y., S. M. Russell, G. Appleyard, C. M. Brand, and J. Beale. 1984. Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity. Eur. J. Immunol. 14:350-356.
12. Mills, K. H., A. Barnard, J. Watkins, and K. Redhead. 1993. Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model. Infect. Immun. 61:399-410.
13. Mills, K. H. G., M. Ryan, E. Ryan, and B. P. Mahon. 1998. A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis. Infect. Immun. 66:594-602.
14. Preston, N. W. 1988. Pertussis today, p. 1-18. In A. C. Wardlaw and R. Parton (ed.), Pathogenesis and immunity in pertussis. John Wiley & Sons Ltd., Chichester, United Kingdom.
15. Redhead, K., J. Watkins, A. Barnard, and K. H. Mills. 1993. Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity. Infect. Immun. 61:3190-3198.
16. Small, P. A., Jr. 1990. Influenza: pathogenesis and host defense. Hosp. Pract. 25:57-62.
17. Stehr, K., J. D. Cherry, U. Heininger, S. Schmitt-Grohe, M. Uberall, S. Laussucq, T. Eckhardt, M. Meyer, R. Engelhardt, and P. Christenson. 1998. A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccine. Pediatrics 101: 1-11.
18. Van den Akker, W. M. 1998. The filamentous hemagglutinin of Bordetella parapertussis is the major adhesin in the phase-dependent interaction with NCI-H292 human lung epithelial cells. Biochem. Biophys. Res. Commun. 252:128-133.
19. Watanabe, M., K. Funaishi, T. Takeo, and M. Endoh. 2000. Efficacy of pertussis vaccines consisted of antigens detoxified with tea-leaf catechins. Vaccine 19:1204-1210.
20. Watanabe, M., and M. Nagai. 2001. Reciprocal protective immunity against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection. Infect. Immun. 69:6981-6986.
21. Watanabe, M., M. Nagai, K. Funaishi, and M. Endoh. 2000. Efficacy of chemically cross-linked antigens for acellular pertussis vaccine. Vaccine 19: 1199-1203.
22. Willems, R. J., J. Kamerbeek, C. A. Geuijen, J. Top, H. Gielen, W. Gaastra, and F. R. Mool. 1998. The efficacy of a whole cell pertussis vaccine and fimbriae against Bordetella pertussis and Bordetella parapertussis infections in a respiratory mouse model. Vaccine 16:410-416.